Immediate Impact
55 standout
Citing Papers
H2AX: A key player in DNA damage response and a promising target for cancer therapy
2024 Standout
Epigenetics-targeted drugs: current paradigms and future challenges
2024 Standout
Works of Eva Widing being referenced
Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Eva Widing | 100 | 88 | 37 | 115 | 10 | 278 | |
| Birgit Teichmann | 144 | 101 | 6 | 64 | 10 | 320 | |
| Seki | 40 | 120 | 12 | 72 | 12 | 279 | |
| Joanna Laurson-Doube | 56 | 94 | 5 | 38 | 11 | 248 | |
| Jung‐Yi Lin | 120 | 50 | 15 | 45 | 15 | 248 | |
| Erik Hameister | 136 | 54 | 6 | 38 | 11 | 280 | |
| Maxine Hetherington | 45 | 47 | 43 | 11 | 15 | 271 | |
| Jeannine Garnett | 105 | 129 | 8 | 13 | 17 | 311 | |
| Robert Welschinger | 60 | 90 | 6 | 42 | 16 | 282 | |
| K Shimada | 36 | 26 | 3 | 157 | 8 | 334 | |
| Maria Vittoria Gazzola | 33 | 63 | 60 | 13 | 13 | 329 |
All Works
Loading papers...